Contracts › 75A50118C00019
75A50118C00019: Procurement and Late-Stage Development of Smallpox Antiviral Drug(S) Igf::Ot::Igf
Awarded to Siga Technologies, Inc. by Office of Assistant Secretary for Preparedness and Response.
$626.5Mobligated
$626.5Mpotential value
30 August 2029current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50118C00019 |
|---|---|
| Awardee | Siga Technologies, Inc. |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN13 Health R&D Services; Health Care Services; Experimental Development |
| Place of performance | OR |
| Offers received | 1 |
| Period of performance | 10 September 2018 to 30 August 2029 |
| Potential end | 30 August 2029 |
| Estimated recompete solicitation | ~Q1 2029 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record